Healthlead PCL (BKK:HL)

Market Cap	1.90B
Revenue (ttm)	2.02B
Net Income (ttm)	78.26M
Shares Out	272.00M
EPS (ttm)	0.29
PE Ratio	24.14
Forward PE	n/a
Dividend	0.15 (2.11%)
Ex-Dividend Date	Mar 14, 2025

Volume	197,417
Average Volume	385,182
Open	7.25
Previous Close	7.10
Day's Range	6.90 - 7.25
52-Week Range	6.50 - 12.60
Beta	0.17
RSI	34.84
Earnings Date	Feb 25, 2025

About Healthlead PCL

Healthlead Public Company Limited, together with its subsidiaries, engages in development, import, and distribution of drugs, pharmaceuticals, cosmetic products, dietary supplements, medical equipment, other health products. It offers medicines, medical supplies, and medical devices, as well as disinfectant and deodorizing products comprising mask products under the iCare, Pharmax, vitaminclub, and Super Drug brands; and dietary supplements under the PRIME and Besuto brand names. Healthlead Public Company Limited was incorporated in 2018 and is...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 2018
• Country: Thailand
• Stock Exchange: Stock Exchange of Thailand
• Ticker Symbol: HL

Financial Performance

In 2024, Healthlead PCL's revenue was 2.02 billion, an increase of 21.61% compared to the previous year's 1.66 billion. Earnings were 78.26 million, an increase of 4.80%.